Use of the PLATO Questionnaire to Assess Oral Appliance Therapy in Adults with Obstructive Sleep Apnea
Led by Nevada Dental Sleep · Updated on 2026-10-08
20
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a prospective, real-world observational study in a dental sleep practice to evaluate the use of the PLATO questionnaire for patients undergoing oral appliance therapy for obstructive sleep apnea OSA. The PLATO questionnaire is a patient-reported tool developed by the American Academy of Sleep Medicine to better assess treatment experiences in OSA.
Patients included are those diagnosed with mild to moderate OSA prescribed a custom oral appliance mandibular advancement device or severe OSA patients who decline continuous positive airway pressure CPAP therapy. The study focuses on assessing changes in PLATO questionnaire scores before and after the oral appliance titration period, which typically involves 10 to 30 days from initial assessment to device delivery, followed by 30 to 90 days of adjustment based on patient response.
Participants will complete the PLATO questionnaire at baseline and after the titration period to monitor treatment outcomes. The study collects data on patient-reported experiences through the PLATO tool and tracks changes in scores to evaluate the feasibility of integrating this questionnaire into dental sleep practices. The total duration includes initial assessment, device delivery, and follow-up over several weeks to months.
CONDITIONS
Brief Title
Application of the Patient-reported Longitudinal Assessment Tool for OSA (PLATO) Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
AHI above 30 if CPAP therapy is refused or not tolerated
Ownership of a smartphone for home sleep testing
Currently using only oral appliance therapy, without combination treatments
You will not qualify if you...
Pregnancy
Use of home oxygen
Serious or uncontrolled illnesses such as angina, myocardial infarction, cancer, stroke, dementia, congestive heart failure, or chronic respiratory illness
Significant sleep-related disorders other than OSA
Investigator's judgment that participation is not in the patient's best interest
Any condition or circumstance likely to prevent study completion, accurate data collection, or that may bias results
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Oral Appliance Titration
Duration - Approximately 40 to 120 days
Participants undergo initial assessment, receive the oral appliance device, and adjust therapy based on response.
Initial assessment to device delivery takes 10 to 30 days; follow-up adjustment lasts 30 to 90 days
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Comparing PAP Therapy, Dental Devices, and Atomoxetine-Oxybutynin Medications for Adults with Obstructive Sleep Apnea
Observational Study of a Modified Baveno Classification for Obstructive Sleep Apnea
Based on Sleepiness and Heart Health Scores in Adults
Use of the PLATO Questionnaire to Assess Oral Appliance Therapy in Adults with Obstructive Sleep Apnea
Study of Different CPAP Mask Exhaust Flows During Sleep in Adults with Obstructive Sleep Apnea
Study of Motivation and Personality Factors to Improve CPAP Use in Adults with Severe Obstructive Sleep Apnea
Comparing Mandibular Advancement Device and CPAP Therapy for Improving Cognitive Function in Adults with Sleep Apnea and Cardiovascular Risk
Study Using Facial Scans, Videos, and Heart Rate to Help Diagnose Obstructive Sleep Apnea in Adults
Evaluating a New Electromyography Method to Diagnose Obstructive Sleep Apnea Using Mouth and Throat Muscle Activity
Digital-supported Orofacial Myofunctional Therapy for Adults with Mild to Moderate Obstructive Sleep Apnea A Pilot Randomized Trial
Safety and Effectiveness Study of IHL-42X in Adults With Obstructive Sleep Apnea Using Multiple Doses in a Randomized Crossover Design
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The Patient-reported Longitudinal Assessment Tool for OSA (PLATO): development and validation of a new clinical tool to assess response to obstructive sleep apnea treatment in adults.
Douglas Kirsch, Fariha Abbasi-Feinberg, Charles Davies...